Comparison of Knowledge Regarding Human Papillomavirus (HPV) and Cervical Cancer in Students with or without Sexual Intercourse
The aim of our study was to compare knowledge of regarding HPV and cervical cancer in female student of 18 to 26 years old, with or without sexual intercourse. We conducted a questionnaire survey of the students (N=568), in Faculty of Natural Sciences, Tirana, Albania. Sexually experienced students were more likely to have heard of risk factors such as multiple sex partners, sexual intercourse before age 18, having contracted any sexually transmitted diseases, having genital warts, smoking cigarettes, use of oral contraceptive, poor diet or nutrition and using tampons. No significant sexually experience differences were observed in knowledge of the way of transmission of the virus associated with cervical cancer knowledge, the virus associated with cervical cancer knowledge, the prevention of cervical cancer knowledge. On the other hand strong significant sexually experience differences were observed in knowledge of the diagnostic way of cervical cancer and what HPV can cause knowledge.
[1] F. Bakiri , T. Rexha , A. Mitre, The Seroprevalence of 35 Types of
Human Papillomavirus in Albanian Women. Journal International
Environmental Application Science, Turkey. Volume VII (Issue IV),
2012, pp. 734-737.
[2] J. Cuzick, P. Sasieni , P. Davies , J. Adams , C. Normand , A. Frater , M.
van Ballegooijen , E. van den Akker , A systematic review of the role of
human papillomavirus testing within a cervical screening programme.
Health Technology Assessment, 3, 1999, pp. 1–204.
[3] J. Douglas, Papillomavirus. In L. Goldman & D. Ausiello (Eds.), Cecil's
Medicine, (23rd ed.). Philadelphia, PA: Saunders Elsevier, 2008.
[4] E. F. Dunne, E. R. Unger, M. Sternberg, G. McQuillan , D. C. Swan, S.S
Patel . L.E. Markowitz, Prevalence of HPV infection among females in
the United States. Journal of the American Medical Association, 297(8),
2007, pp. 813‐819.
[5] L. Eckert, G. Lentz, Infections of the lower genital tract: vulva, vagina,
cervix, toxicshock syndrome, HIV infections. In V. Katz, G. Lentz, R.
Lobo, & D. Gershenson, (Eds.). Comprehensive Gynecology (5th ed.).
Philadelphia, PA: Mosby, 2007.
[6] R. Fielder, M. Carey, Predictors and consequences of sexual “hookups”
among college students: A short-term prospective study. Archives of
Sexual Behavior, Online First, 2009.
[7] K. Filipi, A.Tedeschini, F. Paolini, S. Celicu, S. Morici, M. Kota, E.
Bucaj. F. de Marco, Genital human papillomavirus infection and
genotype prevalence among albanian women: a cross-sectional study. j
med virol.; 82(7), 2010, 1192-6.
[8] R. Herrero, A. Hildesheim, C. Bratti, M. Sherman, M. Hutchinson, J.
Morales, et al,. A population‐based study of all grades of cervical
neoplasia in rural Costa Rica. Journal of the National Cancer Institute,
92, 2000, pp. 6464–6473.
[9] K. Ingledue , R. Cottrell, A. Bernard, College women’s knowledge,
perceptions and preventative behaviors regarding human papillomavirus
infection and cervical cancer. American Journal of Health Studies,2004,
19, pp. 28-34.
[10] E. Lazcano‐Ponce, R. Herrero , N. Munoz , A. Cruz , K. V. Shah , P.
Alonso, et al, Epidemiology of HPV Infection among women Mexican
women with normal cervical cytology. International Journal of Cancer,
2001, 91, pp. 412‐420.
[11] L. E. Markowitz, E. F. Dunne, M. Saraiya, H. W. Lawson, H. Chesson,
E. R. Unger, Quadrivalent Human Papillomavirus Vaccine.
Recommendations of the Advisory Committee on Immunization
Practices. CDC: Morbidity and Mortality Weekly Reports, 56, 2007, pp.
1–24.
[12] M. Molano, H. Posso, E. Weiderpass , A. J. van den Brule, M.
Ronderos, S. Franceschi, et al, Prevalence and determinants of HPV
infection among Colombian women with normal cytology. British
Journal of Cancer, 87, 2002, 324‐33.
[13] N. Munoz, F. X. Bosch, S. de Sanjose , R. Herrero, X. Castellsague,
K.V. Shah, et al,.Epidemiologic classification of Human Papillomavirus
types associated with cervical cancer. New England Journal of
Medicine, 2003, 348(6), pp. 518‐527.
[14] D. Parkin, The global health burden of infection‐ associated cancers in
the year 2002. International Journal of Cancer, 2006, 118, pp.
3030‐3044.
[15] K.S. Reisinger, S.L. Block, E. Lazcano-Ponce , R. Samakoses, M.T.
Esser, J. Erick, et al, Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11,16, 18 L1 virus-like
particle vaccine in preadolescents and adolescents: A randomized
controlled trial. The Pediatric Infectious Disease Journal, 2007, 26(3),
pp. 201-209.
[16] J. Shepherd, R. Weston, G. Peersman, I.Z. Napuli, Interventions for
encouraging sexual lifestyles and behaviours intended to prevent
cervical cancer, 2000. In: The Cochrane Library Issue 1. Oxford: Update
software.
[17] S. C. Thompson, K. Anderson, D. Freedman, J. Swan, Illusions of safety
in a risky world: A study of college students' condom use. Journal of
Applied Social Psychology, 2006, 26(3), pp. 189-210.
[18] L. P. Wong, I.C. Sam, Ethnically diverse female university students’
knowledge and attitudes toward human papillomavirus (HPV), HPV
vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol, 148,
2010.
[19] World Health Organization (WHO), Human Papillomavirus and cervical
cancer, 2008. Available at http://www.who.int/immunization/topics/hpv
/en/
[20] WHO/ICO Information Centre on HPV and Cervical Cancer (HPV
Information Centre). Human Papillomavirus and Related Cancers in
Albania, 2010. Available at www. who. int/ hpvcentre
[21] M. A. Gerend, S. C. Lee, J. E. Shepherd, Predictors of human
papillomavirus vaccination acceptability among underserved women.
Sex Transm Dis, 2007; 34: 468 –71.
[22] G. D. Zimet , Improving adolescent health: Focus on HPV vaccine
acceptance. J Adolesc Health 2005; 37 (Suppl):S17–23.
[1] F. Bakiri , T. Rexha , A. Mitre, The Seroprevalence of 35 Types of
Human Papillomavirus in Albanian Women. Journal International
Environmental Application Science, Turkey. Volume VII (Issue IV),
2012, pp. 734-737.
[2] J. Cuzick, P. Sasieni , P. Davies , J. Adams , C. Normand , A. Frater , M.
van Ballegooijen , E. van den Akker , A systematic review of the role of
human papillomavirus testing within a cervical screening programme.
Health Technology Assessment, 3, 1999, pp. 1–204.
[3] J. Douglas, Papillomavirus. In L. Goldman & D. Ausiello (Eds.), Cecil's
Medicine, (23rd ed.). Philadelphia, PA: Saunders Elsevier, 2008.
[4] E. F. Dunne, E. R. Unger, M. Sternberg, G. McQuillan , D. C. Swan, S.S
Patel . L.E. Markowitz, Prevalence of HPV infection among females in
the United States. Journal of the American Medical Association, 297(8),
2007, pp. 813‐819.
[5] L. Eckert, G. Lentz, Infections of the lower genital tract: vulva, vagina,
cervix, toxicshock syndrome, HIV infections. In V. Katz, G. Lentz, R.
Lobo, & D. Gershenson, (Eds.). Comprehensive Gynecology (5th ed.).
Philadelphia, PA: Mosby, 2007.
[6] R. Fielder, M. Carey, Predictors and consequences of sexual “hookups”
among college students: A short-term prospective study. Archives of
Sexual Behavior, Online First, 2009.
[7] K. Filipi, A.Tedeschini, F. Paolini, S. Celicu, S. Morici, M. Kota, E.
Bucaj. F. de Marco, Genital human papillomavirus infection and
genotype prevalence among albanian women: a cross-sectional study. j
med virol.; 82(7), 2010, 1192-6.
[8] R. Herrero, A. Hildesheim, C. Bratti, M. Sherman, M. Hutchinson, J.
Morales, et al,. A population‐based study of all grades of cervical
neoplasia in rural Costa Rica. Journal of the National Cancer Institute,
92, 2000, pp. 6464–6473.
[9] K. Ingledue , R. Cottrell, A. Bernard, College women’s knowledge,
perceptions and preventative behaviors regarding human papillomavirus
infection and cervical cancer. American Journal of Health Studies,2004,
19, pp. 28-34.
[10] E. Lazcano‐Ponce, R. Herrero , N. Munoz , A. Cruz , K. V. Shah , P.
Alonso, et al, Epidemiology of HPV Infection among women Mexican
women with normal cervical cytology. International Journal of Cancer,
2001, 91, pp. 412‐420.
[11] L. E. Markowitz, E. F. Dunne, M. Saraiya, H. W. Lawson, H. Chesson,
E. R. Unger, Quadrivalent Human Papillomavirus Vaccine.
Recommendations of the Advisory Committee on Immunization
Practices. CDC: Morbidity and Mortality Weekly Reports, 56, 2007, pp.
1–24.
[12] M. Molano, H. Posso, E. Weiderpass , A. J. van den Brule, M.
Ronderos, S. Franceschi, et al, Prevalence and determinants of HPV
infection among Colombian women with normal cytology. British
Journal of Cancer, 87, 2002, 324‐33.
[13] N. Munoz, F. X. Bosch, S. de Sanjose , R. Herrero, X. Castellsague,
K.V. Shah, et al,.Epidemiologic classification of Human Papillomavirus
types associated with cervical cancer. New England Journal of
Medicine, 2003, 348(6), pp. 518‐527.
[14] D. Parkin, The global health burden of infection‐ associated cancers in
the year 2002. International Journal of Cancer, 2006, 118, pp.
3030‐3044.
[15] K.S. Reisinger, S.L. Block, E. Lazcano-Ponce , R. Samakoses, M.T.
Esser, J. Erick, et al, Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11,16, 18 L1 virus-like
particle vaccine in preadolescents and adolescents: A randomized
controlled trial. The Pediatric Infectious Disease Journal, 2007, 26(3),
pp. 201-209.
[16] J. Shepherd, R. Weston, G. Peersman, I.Z. Napuli, Interventions for
encouraging sexual lifestyles and behaviours intended to prevent
cervical cancer, 2000. In: The Cochrane Library Issue 1. Oxford: Update
software.
[17] S. C. Thompson, K. Anderson, D. Freedman, J. Swan, Illusions of safety
in a risky world: A study of college students' condom use. Journal of
Applied Social Psychology, 2006, 26(3), pp. 189-210.
[18] L. P. Wong, I.C. Sam, Ethnically diverse female university students’
knowledge and attitudes toward human papillomavirus (HPV), HPV
vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol, 148,
2010.
[19] World Health Organization (WHO), Human Papillomavirus and cervical
cancer, 2008. Available at http://www.who.int/immunization/topics/hpv
/en/
[20] WHO/ICO Information Centre on HPV and Cervical Cancer (HPV
Information Centre). Human Papillomavirus and Related Cancers in
Albania, 2010. Available at www. who. int/ hpvcentre
[21] M. A. Gerend, S. C. Lee, J. E. Shepherd, Predictors of human
papillomavirus vaccination acceptability among underserved women.
Sex Transm Dis, 2007; 34: 468 –71.
[22] G. D. Zimet , Improving adolescent health: Focus on HPV vaccine
acceptance. J Adolesc Health 2005; 37 (Suppl):S17–23.
@article{"International Journal of Medical, Medicine and Health Sciences:65219", author = "F. Bakiri and T. Rexha and A. Mitre", title = "Comparison of Knowledge Regarding Human Papillomavirus (HPV) and Cervical Cancer in Students with or without Sexual Intercourse", abstract = "The aim of our study was to compare knowledge of regarding HPV and cervical cancer in female student of 18 to 26 years old, with or without sexual intercourse. We conducted a questionnaire survey of the students (N=568), in Faculty of Natural Sciences, Tirana, Albania. Sexually experienced students were more likely to have heard of risk factors such as multiple sex partners, sexual intercourse before age 18, having contracted any sexually transmitted diseases, having genital warts, smoking cigarettes, use of oral contraceptive, poor diet or nutrition and using tampons. No significant sexually experience differences were observed in knowledge of the way of transmission of the virus associated with cervical cancer knowledge, the virus associated with cervical cancer knowledge, the prevention of cervical cancer knowledge. On the other hand strong significant sexually experience differences were observed in knowledge of the diagnostic way of cervical cancer and what HPV can cause knowledge.
", keywords = "Risk factors, HPV, Cervical cancer, Albanian students. ", volume = "7", number = "2", pages = "117-4", }
